Selected article for: "corticosteroid therapy and long term"
Author: McClure, Tess; Cui, Wanyuan; Asadi, Khashayar; John, Thomas; Testro, Adam
Title: Case of nivolumab-induced sclerosing cholangitis: lessons from long-term follow-up
  • Cord-id: rarmqgam
  • Document date: 2020_9_10
    • ID: rarmqgam
    Snippet: Nivolumab is an immune checkpoint inhibitor used to treat multiple solid-organ malignancies. While many of its immune-related adverse events are well established, nivolumab-induced sclerosing cholangitis remains poorly characterised, with no defined diagnostic criteria. Moreover, data regarding long-term outcomes are particularly lacking. We present a biopsy-proven case of nivolumab-induced sclerosing cholangitis, which uniquely captures 18 months of follow-up post-treatment. Our case highlights
    Document: Nivolumab is an immune checkpoint inhibitor used to treat multiple solid-organ malignancies. While many of its immune-related adverse events are well established, nivolumab-induced sclerosing cholangitis remains poorly characterised, with no defined diagnostic criteria. Moreover, data regarding long-term outcomes are particularly lacking. We present a biopsy-proven case of nivolumab-induced sclerosing cholangitis, which uniquely captures 18 months of follow-up post-treatment. Our case highlights key features of intrahepatic subtype sclerosing cholangitis and suggests durable response to corticosteroid therapy.

    Search related documents:
    Co phrase search for related documents
    • abdominal pain and additional research: 1, 2, 3
    • abdominal pain and liver biopsy: 1, 2, 3, 4
    • abdominal pain and liver function: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • abdominal pain and liver function test: 1
    • abdominal pain and liver ultrasound: 1, 2
    • abdominal pain and long term outcome: 1, 2, 3
    • additional research and liver function: 1
    • additional research and long term outcome: 1, 2
    • liver biopsy and long term outcome: 1
    • liver biopsy and lung adenocarcinoma: 1
    • liver function and long term outcome: 1, 2